Suppr超能文献

免疫抑制药理制剂对体外细胞毒性T淋巴细胞和抑制性T淋巴细胞诱导的影响。

The effects of immunosuppressive pharmacological agents on the induction of cytotoxic and suppressor T lymphocytes in vitro.

作者信息

Bucy R P

机构信息

Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110.

出版信息

Immunopharmacology. 1988 Mar-Apr;15(2):65-72. doi: 10.1016/0162-3109(88)90053-7.

Abstract

The immune system is regulated by the interactions among several distinct functional subsets of T cells. The action of several commonly used immunosuppressive drugs on the activation of cytotoxic T lymphocytes (CTL) and suppressor T lymphocytes (Ts) in the primary mixed lymphocyte reaction (MLR) was investigated. Cyclosporin A, hydrocortisone, and azathioprine were all found to inhibit both CTL and Ts activation when present at pharmacological doses in culture. When these drug-inhibited cultures were reconstituted with interleukin-2, however, clear differences between the effects of these drugs was observed. Cyclosporin A and hydrocortisone allowed the selective activation of Ts in the presence of interleukin-2, while azathioprine inhibition was not reversed by interleukin-2. Thus, CTL precursors appear to be directly inhibited by all of these drugs, but Ts precursors apparently are not inhibited by cyclosporin A or hydrocortisone provided interleukin-2 is present. These findings are discussed in terms of the activation requirements of CTL vs. Ts and the implications of the selective activation of alloantigen-specific Ts for prevention of allograft rejection.

摘要

免疫系统受几种不同功能的T细胞亚群间相互作用的调节。研究了几种常用免疫抑制药物在初次混合淋巴细胞反应(MLR)中对细胞毒性T淋巴细胞(CTL)和抑制性T淋巴细胞(Ts)激活的作用。当在培养中以药理剂量存在时,环孢素A、氢化可的松和硫唑嘌呤均被发现可抑制CTL和Ts的激活。然而,当用白细胞介素-2重建这些药物抑制的培养物时,观察到了这些药物作用之间的明显差异。在白细胞介素-2存在的情况下,环孢素A和氢化可的松可使Ts选择性激活,而硫唑嘌呤的抑制作用不能被白细胞介素-2逆转。因此,CTL前体似乎被所有这些药物直接抑制,但如果存在白细胞介素-2,Ts前体显然不会被环孢素A或氢化可的松抑制。根据CTL与Ts的激活要求以及同种异体抗原特异性Ts的选择性激活对预防同种异体移植排斥反应的意义对这些发现进行了讨论。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验